Hancock Whitney’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.44M Sell
5,094
-157
-3% -$85.2K 0.04% 287
2025
Q4
$3.04M Sell
5,251
-11
-0.2% -$6.22K 0.05% 233
2025
Q3
$2.55M Sell
5,262
-87
-2% -$40.5K 0.05% 263
2025
Q2
$2.17M Sell
5,349
-114
-2% -$47.7K 0.04% 280
2025
Q1
$2.72M Buy
5,463
+77
+1% +$41.7K 0.09% 161
2024
Q4
$2.8M Buy
5,386
+30
+0.6% +$16.5K 0.09% 160
2024
Q3
$3.31M Sell
5,356
-45
-0.8% -$26.6K 0.11% 136
2024
Q2
$2.99M Sell
5,401
-62
-1% -$35.5K 0.1% 142
2024
Q1
$3.18M Sell
5,463
-1,392
-20% -$781K 0.11% 142
2023
Q4
$3.64M Sell
6,855
-1,959
-22% -$948K 0.14% 128
2023
Q3
$4.46M Sell
8,814
-430
-5% -$229K 0.18% 106
2023
Q2
$4.82M Sell
9,244
-382
-4% -$206K 0.19% 104
2023
Q1
$5.55M Sell
9,626
-1,202
-11% -$677K 0.22% 98
2022
Q4
$5.96M Sell
10,828
-67
-0.6% -$35.5K 0.23% 95
2022
Q3
$5.53M Sell
10,895
-294
-3% -$165K 0.24% 91
2022
Q2
$6.08M Sell
11,189
-376
-3% -$207K 0.24% 88
2022
Q1
$6.83M Sell
11,565
-418
-3% -$240K 0.23% 88
2021
Q4
$8M Sell
11,983
-145
-1% -$90.5K 0.25% 90
2021
Q3
$6.93M Sell
12,128
-1,443
-11% -$792K 0.24% 91
2021
Q2
$6.85M Sell
13,571
-486
-3% -$229K 0.22% 98
2021
Q1
$6.42M Sell
14,057
-793
-5% -$378K 0.22% 95
2020
Q4
$6.92M Sell
14,850
-1,146
-7% -$537K 0.23% 91
2020
Q3
$7.06M Sell
15,996
-797
-5% -$329K 0.26% 86
2020
Q2
$6.08M Sell
16,793
-21,870
-57% -$7.33M 0.23% 92
2020
Q1
$11M Sell
38,663
-12,497
-24% -$3.94M 0.43% 49
2019
Q4
$16.6M Sell
51,160
-2,148
-4% -$651K 0.54% 31
2019
Q3
$15.5M Sell
53,308
-1,449
-3% -$415K 0.51% 36
2019
Q2
$16.1M Sell
54,757
-2,869
-5% -$790K 0.51% 31
2019
Q1
$15.8M Sell
57,626
-2,268
-4% -$564K 0.51% 32
2018
Q4
$13.4M Sell
59,894
-7,580
-11% -$1.78M 0.45% 41
2018
Q3
$16.5M Buy
67,474
+7,641
+13% +$1.76M 0.47% 38
2018
Q2
$12.4M Sell
59,833
-1,174
-2% -$249K 0.57% 57
2018
Q1
$12.6M Sell
61,007
-1,004
-2% -$211K 0.56% 67
2017
Q4
$11.8M Sell
62,011
-414
-0.7% -$79.3K 0.49% 78
2017
Q3
$11.8M Buy
+62,425
New +$11.3M 0.5% 83
2015
Q3
Sell
-1,784
Closed -$240K 594
2015
Q2
$240K Hold
1,784
0.01% 478
2015
Q1
$240K Sell
1,784
-115,814
-98% -$14.9M 0.01% 478
2014
Q4
$14.7M Sell
117,598
-6,990
-6% -$850K 0.56% 52
2014
Q3
$15.2M Sell
124,588
-860
-0.7% -$105K 0.58% 51
2014
Q2
$14.8M Sell
125,448
-6,722
-5% -$791K 0.54% 60
2014
Q1
$15.9M Sell
132,170
-11,658
-8% -$1.39M 0.62% 41
2013
Q4
$16M Buy
143,828
+855
+0.6% +$85K 0.66% 42
2013
Q3
$13.2M Sell
142,973
-11,213
-7% -$1.01M 0.61% 53
2013
Q2
$13M Buy
+154,186
New +$12.8M 0.65% 47

Other funds holding TMO

Hancock Whitney's TMO Position: Q1 2026 in Review

Hancock Whitney reduced its Thermo Fisher Scientific (TMO) stake by 3% in Q1 2026, selling an estimated $85.2K and leaving 5,094 shares worth $2.44M. The position accounts for 0.04% of the portfolio, ranked #287.

Hancock Whitney first reported a position in TMO in Q2 2013 and has held it in 44 quarters since. The position peaked at $16.6M in Q4 2019. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Hancock Whitney held 5,094 shares of Thermo Fisher Scientific worth $2.44M as of Q1 2026.
  • Hancock Whitney sold 157 Thermo Fisher Scientific shares in Q1 2026, an estimated $85.2K.
  • Thermo Fisher Scientific made up 0.04% of Hancock Whitney's portfolio in Q1 2026, its #287 holding.
  • Hancock Whitney first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 44 quarters since.
  • Hancock Whitney's Thermo Fisher Scientific position peaked at $16.6M in Q4 2019.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Hancock Whitney's 13F filing for Q1 2026, filed 15 May 2026.